These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 27973629)

  • 1. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
    Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
    Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism.
    Ahmed T; Liu FF; Wu XY
    Expert Opin Drug Deliv; 2024 Feb; 21(2):245-278. PubMed ID: 38344771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN).
    Li Y; Taulier N; Rauth AM; Wu XY
    Pharm Res; 2006 Aug; 23(8):1877-87. PubMed ID: 16850265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-coated polymeric nanoparticles for cancer drug delivery.
    Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
    Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.
    Sgorla D; Bunhak ÉJ; Cavalcanti OA; Fonte P; Sarmento B
    Expert Opin Drug Deliv; 2016 Sep; 13(9):1301-9. PubMed ID: 27110648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the transformability of polymer-lipid hybrid nanoparticles and nanomaterial-biology interplay to facilitate tumor penetration, cellular uptake and intracellular targeting of anticancer drugs.
    Amini MA; Ahmed T; Liu FF; Abbasi AZ; Soeandy CD; Zhang RX; Prashad P; Cummins CL; Rauth AM; Henderson JT; Wu XY
    Expert Opin Drug Deliv; 2021 Jul; 18(7):991-1004. PubMed ID: 33703991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.
    Li Y; Abbaspour MR; Grootendorst PV; Rauth AM; Wu XY
    Eur J Pharm Biopharm; 2015 Aug; 94():170-9. PubMed ID: 25986587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Polymer-Lipid Hybrid Nanoparticle for the Improvement of Topotecan Hydrochloride Physicochemical Properties.
    Silva EJ; Souza LG; Silva LAD; Taveira SF; Guilger RC; Liao LM; Queiroz Junior LHK; Santana MJ; Marreto RN
    Curr Drug Deliv; 2018; 15(7):979-986. PubMed ID: 29243576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform.
    Mandal B; Bhattacharjee H; Mittal N; Sah H; Balabathula P; Thoma LA; Wood GC
    Nanomedicine; 2013 May; 9(4):474-91. PubMed ID: 23261500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications.
    Jose C; Amra K; Bhavsar C; Momin M; Omri A
    Crit Rev Ther Drug Carrier Syst; 2018; 35(6):555-588. PubMed ID: 30317969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel surface modified polymer-lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation.
    Pardeshi CV; Belgamwar VS; Tekade AR; Surana SJ
    J Mater Sci Mater Med; 2013 Sep; 24(9):2101-15. PubMed ID: 23728521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors.
    Rizwanullah M; Alam M; Harshita ; Mir SR; Rizvi MMA; Amin S
    Curr Pharm Des; 2020; 26(11):1206-1215. PubMed ID: 31951163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Acting Efavirenz and HIV-1 Fusion Inhibitor Peptide Co-loaded Polymer-Lipid Hybrid Nanoparticles: Statistical Optimization, Cellular Uptake, and
    Surve DH; Jirwankar YB; Dighe VD; Jindal AB
    Mol Pharm; 2020 Oct; 17(10):3990-4003. PubMed ID: 32808785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-Polymer Hybrid Nanoparticles Synthesized via Lipid-Based Surface Engineering for a robust drug delivery platform.
    Soomherun N; Kreua-Ongarjnukool N; Niyomthai ST; Chumnanvej S
    Colloids Surf B Biointerfaces; 2024 May; 237():113858. PubMed ID: 38547797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
    Rao S; Prestidge CA
    Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of a hybrid polymer-lipid nanocarrier for the nasal delivery of tenofovir disoproxil fumarate: physicochemical, molecular, microstructural, and stability evaluation.
    Pokharkar VB; Jolly MR; Kumbhar DD
    Eur J Pharm Sci; 2015 Apr; 71():99-111. PubMed ID: 25708940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.